血清载脂蛋白A5与糖尿病肾病关系探讨

来源 :第十届全国检验与临床学术会议暨2015年中国医师协会检验医师年会 | 被引量 : 0次 | 上传用户:wangliubaobao
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的 探讨血清载脂蛋白A5(ApoA5)水平与糖尿病肾病患者之间关系。方法 选取198 例糖尿病患者,分为糖尿病肾病组86 例,糖尿病不伴肾病组112 例;另选取120 名健康体检者作为对照组。采用ELISA 法测定ApoA5 水平,并进行相关性分析。
其他文献
Theranostics is emerging as a popular strategy for cancer therapy thanks to the development of nanotechnology[1].
会议
The RNA interference technique has drawn great attention in cancer treatment over the past decade.
会议
Contact angle hysteresis(CAH)is a ubiquitous phenomenon in surface science,which affects dynamic process of wetting/dewetting.
会议
会议
Development of non-viral gene delivery carriers has attracted tremendous attentions in recent years.
会议
Detoxification is a pivotal treatment procedure for patients suffering from intoxication.The existing antidotes are limited to a small number of toxic agents.
会议
Intelligent nanogels which are responsive to environmental conditions(temperature,pH,light and magnetic field)have attracted much attention in various biomedical applications,including bioimaging,bios
会议
A huge challenge,plasmonic nanomaterials,drug@micelles@gold nanocages,have been developed as photo-thermal and chemotherapy agents for the synergistic effects of cancer therapy and for location of the
会议
在不改变氨基酸序列的前提下,对Cys C 的编码基因进行大肠杆菌同义密码子偏好性优化后,人工合成其序列,PCR 扩增Cys C 基因,其产物连接到pMD18-T 质粒,酶切并回收目的片段后克隆到表达载体pET-32a,然后将重组质粒pET-32a-CysC 转化大肠杆菌ER2566,大量表达后利用Westen Blotting 及ELISA 进行重组蛋白的活性及抗原性鉴定。